The first thing you cut when budgets tighten is usually the one that costs you more by cutting it. And in marketing, that’s R&D.
And listen, I get it. It’s the easiest cut in the world to justify. You’re not leaving a client hanging. You’re not missing a deadline. There’s no immediate ROI riding on it. So when you go hunting for something to trim, R&D practically raises its own hand.
But that’s exactly the trap. I’ve made the case before that R&D deserves a protected line in your budget. Real dollars for the messy, will-this-work experimentation that keeps you ahead. Take that line away, and the cost is real. It just doesn’t land in this quarter’s P&L. It lands later, and it lands in one of three places.
1. The compounding gap
Cut R&D and you cut more than a budget line. You cut the investment, the hours, the reps.
Your competitors don’t stop. While you’re sitting it out, they’re still testing, still learning, still building. When you decide to jump back in, they’ve got a head start. And that’s not a gap you buy your way out of. Maybe you spend your way closer. But by then it costs you more than it ever would have to just keep going.
That’s what skipping the reps really does. You don’t stay still, you fall behind. Companies without an R&D habit end up perpetually reactive, reaching for channels and tactics only after they’ve gotten expensive and crowded, long after the first-mover advantage is gone.
2. The reentry
Killing R&D is how you lose the muscle.
It works like training. Stop, and getting back to where you were is harder than it ever was to maintain. The habits of testing, the reps of trying new things, and the culture of failing small so you can learn big aren’t things that can survive a pause. You’d have to rebuild it from scratch.
And that rebuilding costs far more than the marginal dollars you thought you were saving. You didn’t save the money. You paid it later, with interest.
3. False savings
That’s the real trick of this cut. You don’t remove the cost. You defer it.
You push it to a later moment. Or to the day you’re forced to react. Because competitors are moving, the industry is shifting fast, and you no longer hold the first-mover advantage you used to. The bill still comes. It just comes when you have the least control over it, and it’s bigger.
Kill things for the right reasons
None of this means you never stop a project. You should. But kill something because the data tells you to. Kill it because the output isn’t what you expected. That’s discipline. That’s R&D working exactly as it should: deliberate and honest about what’s not landing.
Cutting the budget because things got expensive, or because something spooked you? That’s the mistake. That’s panic. The difference is everything.
It’s the same rule we held ourselves to with AI spend. Make the bet because the hypothesis is solid. The second something isn’t working, stop it and move on. That’s how experimentation stays cheap, and it’s the opposite of the chaos people picture when they hear “R&D.”
You already decided this mattered
Here’s the part that gets me. If you’ve already made R&D its own category, then you’ve already decided it matters. So cutting it the second things tighten just undoes your own call.
And it’s the easiest cut to talk yourself into, right? R&D doesn’t beg for your attention. Nothing breaks tomorrow if it’s gone. Which is exactly why pulling back on it the moment revenue slows is the most common budgeting mistake we see…and often the most expensive one.
A downturn is when experimentation is cheapest and finding your next growth surface pays off the most. It’s the best possible time to be running small, smart bets. And it’s the exact moment most companies stop.
So don’t undo your own decision. Keep the line, keep the reps, and kill only what the data tells you to. The cheapest thing to cut is almost always the most expensive thing to lose.
